PHARMACOTHERAPY IN AGE-RELATED MACULAR DEGENERATION
Ahmed Abdel Moneim Mahrous;
Abstract
Age-related macular degeneration (AMD) is the most common cause of legal blindness in patients older than 65 years of age in the western world. It is classified in two categories: non-neovascular (dry, atrophic) and neovascular (wet, exudative).
Blindnes
Blindnes
Other data
| Title | PHARMACOTHERAPY IN AGE-RELATED MACULAR DEGENERATION | Authors | Ahmed Abdel Moneim Mahrous | Keywords | PHARMACOTHERAPY IN AGE-RELATED MACULAR DEGENERATION | Issue Date | 2009 | Description | Age-related macular degeneration (AMD) is the most common cause of legal blindness in patients older than 65 years of age in the western world. It is classified in two categories: non-neovascular (dry, atrophic) and neovascular (wet, exudative). Blindnes |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.